EG
Not verified

EG 427

What we write about

Advertising / Marketing / Media / CommunicatiBiotechnologyFinanceMedical Health Wellness
05/10/2025
Advertising / Marketing / Media / Communicati
Medical Health Wellness
EG 427 Receives U.S. FDA Fast Track Designation for EG110A DNA Medicine in Neurogenic Bladder Patients
Source
1.00
01/10/2025
Advertising / Marketing / Media / Communicati
Medical Health Wellness
EG 427 annonce des résultats cliniques initiaux majeurs avec EG110A, son médicament à ADN chez des patients atteints de vessie neurogène
Source
1.00
01/10/2025
Advertising / Marketing / Media / Communicati
Medical Health Wellness
EG 427 Announces Compelling Initial Topline Clinical Results with EG110A DNA Medicine in Neurogenic Bladder Patients
Source
1.00
Press Release cover image
12/05/2025
Advertising / Marketing / Media / Communicati
Medical Health Wellness
EG 427 highlights at ASGCT major advances made with its HERMES platform in neurology using versatile non-replicative herpes vectors
Source
1.00

Contact details

Social Media

Followers
0
Compatibility
0